ARS Pharmaceuticals, Inc.

NasdaqGM:SPRY Stock Report

Market Cap: US$915.7m

ARS Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:SPRY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Mar 24BuyUS$13,289,410RA Capital Management, L.P.Company1,401,299US$9.79
29 Sep 23BuyUS$319,954Alexander FitzpatrickIndividual86,258US$3.78
21 Sep 23BuyUS$8,183,526RA Capital Management, L.P.Company2,700,000US$3.83
29 Aug 23SellUS$26,350,000Robert BellIndividual4,250,000US$6.20
29 Aug 23BuyUS$3,100,000OrbiMed Advisors LLCCompany500,000US$6.20
29 Aug 23BuyUS$23,250,000RA Capital Management, L.P.Company3,750,000US$6.20

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SPRY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,0700.0073%
General Public4,871,0085.03%
Hedge Funds11,077,92711.4%
VC/PE Firms20,101,86420.7%
Individual Insiders28,418,22729.3%
Institutions32,418,29833.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.


Top Shareholders

Top 25 shareholders own 89.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Deerfield Management Company, L.P. Series C
11,077,927US$104.7m0%2.06%
11.2%
RA Capital Management, L.P.
10,860,977US$102.6m14.8%1.34%
10.5%
Pratik Shah
10,156,204US$96.0m0%no data
9.54%
OrbiMed Advisors LLC
9,240,887US$87.3m0%1.23%
7.13%
Sarina Tanimoto
6,903,793US$65.2m-3.44%no data
6.15%
Richard Lowenthal
5,961,807US$56.3m1.05%no data
4.35%
Robert Bell
4,213,504US$39.8m0%no data
4.23%
Franklin Resources, Inc.
4,098,243US$38.7m5.94%0.01%
4.14%
SR One Capital Management, LP
4,012,903US$37.9m0%11.02%
3.15%
K2 & Associates Investment Management Inc.
3,054,333US$28.9m19.7%17.13%
2.72%
BlackRock, Inc.
2,637,549US$24.9m2.76%no data
2.17%
The Vanguard Group, Inc.
2,106,486US$19.9m-0.7%no data
2.07%
Baker Bros. Advisors LP
2,006,451US$19.0m0%0.23%
1.97%
Nextech Invest Ltd.
1,910,029US$18.0m0%3.04%
1.65%
Nantahala Capital Management, LLC
1,596,504US$15.1m45.3%1.44%
1.24%
FMR LLC
1,202,311US$11.4m-8.03%no data
1.14%
Sio Capital Management, LLC
1,105,911US$10.5m0%4.2%
0.89%
Geode Capital Management, LLC
864,869US$8.2m7.66%no data
0.68%
Woodline Partners LP
661,414US$6.3m-21.9%0.07%
0.66%
Rubric Capital Management LP
639,203US$6.0m0%0.2%
0.66%
Medical Strategy GmbH, Asset Management Arm
638,980US$6.0m0%0.36%
0.6%
State Street Global Advisors, Inc.
576,980US$5.5m7.61%no data
0.49%
Royce & Associates, LP
473,700US$4.5m2.16%0.04%
0.42%
Tang Capital Management, LLC
409,463US$3.9m0%0.41%
0.39%
Valerie Odegard
382,236US$3.6m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.